Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6801126rdf:typepubmed:Citationlld:pubmed
pubmed-article:6801126lifeskim:mentionsumls-concept:C1155065lld:lifeskim
pubmed-article:6801126lifeskim:mentionsumls-concept:C0023828lld:lifeskim
pubmed-article:6801126lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:6801126lifeskim:mentionsumls-concept:C1514873lld:lifeskim
pubmed-article:6801126lifeskim:mentionsumls-concept:C1709634lld:lifeskim
pubmed-article:6801126pubmed:issue5lld:pubmed
pubmed-article:6801126pubmed:dateCreated1982-5-27lld:pubmed
pubmed-article:6801126pubmed:abstractTextActivation of primed pre-cytolytic T lymphocytes (pCTL) requires two signals: recognition of antigen (signal 1) and interaction with a nonspecific helper factor (signal 2). The two signals necessary for generation of a secondary allogeneic CTL response have been analyzed using H-2Kk in liposomes as the stimulating antigen. Use of the liposomes allows the alloantigen to be separated from responder cells after a brief exposure. Thus, the requirements for effective delivery of each signal could be studied independently. A 12-hr exposure of pCTL to alloantigen was sufficient for optimum signal 1 delivery. pCTL recognition of the antigen occurs during this time, and no requirement for adherent cells could be demonstrated. The structure of the antigen-containing liposomes affects the efficiency of pCTL triggering. Factor(s) necessary for signal 2 could be provided by supernatants from mitogen-stimulated lymphocytes. Alternatively, it could be generated with alloantigen, providing that adherent cells were present. Optimum interaction of factor(s) with pCTL, i.e., optimum delivery of signal 2, occurred only if factor(s) was present at 12 to 24 hr after interaction of pCTL with alloantigen. The results suggest that alloantigen recognition triggers pCTL to synthesize and/or express receptors for the factor(s).lld:pubmed
pubmed-article:6801126pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6801126pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6801126pubmed:languageenglld:pubmed
pubmed-article:6801126pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6801126pubmed:citationSubsetAIMlld:pubmed
pubmed-article:6801126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6801126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6801126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6801126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6801126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6801126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6801126pubmed:statusMEDLINElld:pubmed
pubmed-article:6801126pubmed:monthMaylld:pubmed
pubmed-article:6801126pubmed:issn0022-1767lld:pubmed
pubmed-article:6801126pubmed:authorpubmed-author:BurakoffS JSJlld:pubmed
pubmed-article:6801126pubmed:authorpubmed-author:MescherM FMFlld:pubmed
pubmed-article:6801126pubmed:authorpubmed-author:HerrmannS HSHlld:pubmed
pubmed-article:6801126pubmed:authorpubmed-author:WeinbergerOOlld:pubmed
pubmed-article:6801126pubmed:issnTypePrintlld:pubmed
pubmed-article:6801126pubmed:volume128lld:pubmed
pubmed-article:6801126pubmed:ownerNLMlld:pubmed
pubmed-article:6801126pubmed:authorsCompleteYlld:pubmed
pubmed-article:6801126pubmed:pagination1968-74lld:pubmed
pubmed-article:6801126pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:6801126pubmed:meshHeadingpubmed-meshheading:6801126-...lld:pubmed
pubmed-article:6801126pubmed:meshHeadingpubmed-meshheading:6801126-...lld:pubmed
pubmed-article:6801126pubmed:meshHeadingpubmed-meshheading:6801126-...lld:pubmed
pubmed-article:6801126pubmed:meshHeadingpubmed-meshheading:6801126-...lld:pubmed
pubmed-article:6801126pubmed:meshHeadingpubmed-meshheading:6801126-...lld:pubmed
pubmed-article:6801126pubmed:meshHeadingpubmed-meshheading:6801126-...lld:pubmed
pubmed-article:6801126pubmed:meshHeadingpubmed-meshheading:6801126-...lld:pubmed
pubmed-article:6801126pubmed:meshHeadingpubmed-meshheading:6801126-...lld:pubmed
pubmed-article:6801126pubmed:meshHeadingpubmed-meshheading:6801126-...lld:pubmed
pubmed-article:6801126pubmed:meshHeadingpubmed-meshheading:6801126-...lld:pubmed
pubmed-article:6801126pubmed:meshHeadingpubmed-meshheading:6801126-...lld:pubmed
pubmed-article:6801126pubmed:meshHeadingpubmed-meshheading:6801126-...lld:pubmed
pubmed-article:6801126pubmed:meshHeadingpubmed-meshheading:6801126-...lld:pubmed
pubmed-article:6801126pubmed:meshHeadingpubmed-meshheading:6801126-...lld:pubmed
pubmed-article:6801126pubmed:meshHeadingpubmed-meshheading:6801126-...lld:pubmed
pubmed-article:6801126pubmed:year1982lld:pubmed
pubmed-article:6801126pubmed:articleTitleAnalysis of the two-signal requirement for precursor cytolytic T lymphocyte activation using H-2Kk in liposomes.lld:pubmed
pubmed-article:6801126pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6801126pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:6801126pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6801126lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6801126lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6801126lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6801126lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6801126lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6801126lld:pubmed